Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Reduced CT + Anti-PD-1 as First Line Tx in Vulnerable Older Adults w/Adv <50% PD-L1 Non-Small Cell Lung Cancer (NSCLC)
Apply
Reduced CT & Anti-PD-1
Reduced CT + Anti-PD-1 as First Line Tx in Vulnerable Older Adults w/Adv <50% PD-L1 Non-Small Cell Lung Cancer (NSCLC)
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step